A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Agnieszka Wierzbowska, Anna Czyz, Agnieszka Pluta, Marta Libura, Magdalena Czemerska, Zuzanna Nowicka, Agata Majchrzak, Michał Soin, Anna Kopinska, Krzysztof Wozniczka, Martyna Wlodarczyk, Joanna Dziaczkowska, Krystyna Jagoda, Grzegorz Helbig, Karol Wojcik, Małgorzata Razny, Marta Sobas, Donata Szymczak, Tomasz Wrobel, Andrzej Szczepaniak, Jolanta Parulska, Lidia Gil, Magdalena Dutka, Krzysztof Lewandowski, Maria Bieniaszewska, Tomasz Gromek, Marek Hus, Edyta Cichocka, Janusz Hałka, Elżbieta Patkowska, Jolanta Wozniak, Ewa Lech-Marańda, Agata Obara, Agnieszka Kopacz, Katarzyna Dulik, Sebastian Giebel, Jerzy Holowiecki, Krzysztof Gawronski, Grzegorz Charlinski, Nuria Mencia-Trinchant, Pinkal Desai, Michael Samuel, Justin Kaner, Michal Bar-Natan, Jonathan Canaani, Ellen Ritchie, Monica Guzman, Sylvie Freeman, Gail Roboz
Institutions: Medical University of Lodz, Wroclaw Medical University, Medical University of Warsaw, Medical University of Silesia, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Poznan University of Medical Sciences, Gdańsk Medical University, Medical University of Lublin, Specjalistyczny Szpital Miejski im. M. Kopernika, Instytut Hematologii i Transfuzjologi, University of Rzeszów, The Maria Sklodowska-Curie National Research Institute of Oncology, NewYork–Presbyterian Hospital, Weill Cornell Medicine, University of Birmingham
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417013402
